FDA Calls Off Closed Hearing On Blood Substitute
Cowed by a consumer group lawsuit to open a closed-door meeting, the Food and Drug Administration decided to postpone Friday's hearing to discuss the U.S. Navy's proposition to proceed with a...To view the full article, register now.
Already a subscriber? Click here to view full article